Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ceramides + hyaluronic acid + niacinamide
- Development stage
- Unknown
- Lead developer
- Sterispharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Ceramides + hyaluronic acid + niacinamide is a topical dermatological combination product developed by Sterispharma. It is formulated as a cream designed to address skin dryness, barrier impairment, and uneven skin tone. The formulation leverages three key active ingredients: **ceramides**, which are essential lipids that restore and strengthen the skin's natural protective barrier; **hyaluronic acid**, a potent humectant that attracts and retains moisture within the skin layers; and **niacinamide** (Vitamin B3), which regulates sebum production, improves skin texture, and inhibits melanin synthesis to brighten the complexion. Marketed under the brand name EUROSOFT ADVANCED MATT SKIN MOISTURIZER, the product is classified as a cosmeceutical or dermatological small molecule therapy intended for direct application to the skin.
- Brand names
- EUROSOFT ADVANCED MATT SKIN MOISTURIZER
- Other names
- Ceramides Hyaluronic Acid With Niacinamide Cream
Beyond the preview
Go deeper on ceramides + hyaluronic acid + niacinamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ceramides + hyaluronic acid + niacinamide.